FDA decides to revoke Avastin for breast cancer

December 5, 2011 at 8:47 am Leave a comment

The U.S. Food and Drug Administration has withdrawn its approval of Avastin, a drug commonly used in patients with advanced breast cancer. Dr. Leah Cream, an assistant professor of medicine at Penn State Hershey Cancer Institute, gives her reaction to the decision and explains its significance for breast cancer patients and their doctors.

Entry filed under: Videos.

Penn State Hershey Life Lion: 25 years of critical care in the air Medicine In Blue and White: Episode 2

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


Recent Posts

Enter your email address to subscribe to Penn State Medicine and receive notifications of new posts by email.

Join 397 other followers

Share This Page

Bookmark and Share

Recent Tweets

Categories


%d bloggers like this: